2021 annual financial data
Edesa Biotech 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,732,986.2%.
Operating income was -23.68M USD and net income was -13.34M USD.
Operating cash flow was -13.66M USD.
Get free Edesa Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 500 USD
- Operating income
- -23.68M USD
- Net income
- -13.34M USD
- Operating cash flow
- -13.66M USD